Wall Street Zen upgraded shares of Aurora Cannabis (NASDAQ:ACB – Free Report) from a strong sell rating to a hold rating in a report issued on Saturday.
Separately, Weiss Ratings upgraded shares of Aurora Cannabis from a “sell (d-)” rating to a “sell (d)” rating in a research report on Tuesday, June 16th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold”.
View Our Latest Analysis on ACB
Aurora Cannabis Stock Up 0.3%
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last announced its earnings results on Thursday, June 11th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.14. The firm had revenue of $60.98 million during the quarter, compared to analyst estimates of $54.42 million. Aurora Cannabis had a positive return on equity of 4.37% and a negative net margin of 32.26%. Analysts expect that Aurora Cannabis will post -0.07 EPS for the current year.
Hedge Funds Weigh In On Aurora Cannabis
Several institutional investors have recently bought and sold shares of the company. Two Sigma Investments LP grew its stake in Aurora Cannabis by 7,412.0% in the 3rd quarter. Two Sigma Investments LP now owns 1,149,869 shares of the company’s stock valued at $6,853,000 after buying an additional 1,134,562 shares in the last quarter. Millennium Management LLC lifted its position in shares of Aurora Cannabis by 563.7% during the third quarter. Millennium Management LLC now owns 391,782 shares of the company’s stock worth $2,339,000 after acquiring an additional 332,750 shares in the last quarter. Trexquant Investment LP purchased a new stake in shares of Aurora Cannabis during the fourth quarter worth $590,000. UBS Group AG boosted its holdings in shares of Aurora Cannabis by 136.8% in the third quarter. UBS Group AG now owns 184,190 shares of the company’s stock worth $1,098,000 after acquiring an additional 106,391 shares during the period. Finally, Tidal Investments LLC boosted its holdings in shares of Aurora Cannabis by 6.0% in the second quarter. Tidal Investments LLC now owns 1,509,483 shares of the company’s stock worth $6,400,000 after acquiring an additional 86,045 shares during the period. Hedge funds and other institutional investors own 47.63% of the company’s stock.
Aurora Cannabis Company Profile
Aurora Cannabis Inc (NASDAQ: ACB) is a Canadian licensed producer of medical and consumer cannabis products headquartered in Edmonton, Alberta. Established in 2013, the company operates under Health Canada’s regulations to cultivate, process and distribute a range of cannabis-based offerings. Since its initial public listing in 2017, Aurora has grown into one of the country’s largest growers by cultivation capacity and production output.
The company’s core business spans the cultivation of dried flower, the extraction of cannabis oils and the development of value-added products such as softgels, capsules and topical treatments.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
